Violet Therapeutics Analysis: $11M Raised
What is Violet Therapeutics?
EphB3 inhibitors for neurodegenerative diseases
Location
Cambridge, United States
Employees
1-10
Founded
2021
Product Features & Capabilities
- EphB3 small molecule inhibitor
- C-to-C Engine for cell interaction identification
Use Cases
Targeting neuroinflammation in Alzheimer’s disease; Addressing glial dysfunction in Parkinson’s disease; Developing therapeutics for central nervous system disorders; Investigating microglia-astrocyte interactions; Advancing neurodegenerative disease treatment options
See something that needs updating? Suggest edits to this profile.